Sentences with phrase «medicines company in»

Since that deal began in 2015, the GSK Consumer Healthcare team has been closely involved in the legal and operational aspects of integrating two distinct legacy cultures together under a single business unit to form the leading over-the-counter medicines company in the world.

Not exact matches

So many companies have developed such increasingly effective medicines, such as those that treat more hep C strains with far shorter treatment regimens, that Gilead — a pioneer in the field with Sovaldi and Harvoni — is projecting $ 3.5 billion to $ 4 billion in U.S. sales from these kinds of drugs in 2018, a dramatic drop from nearly $ 13 billion in 2015.

Three rival companies, founded by scientific pioneers in this field — Editas Medicine, Intellia Therapeutics, and CRISPR Therapeutics — have gone public this year, and together command a market cap of nearly $ 1.7 billion.

The company delivers a third of all medicines in North America.

Federal regulations don't allow for - profit companies to practice medicine directly, so 98point6 had to set up smaller corporations in each state.

Keeping an eye on blood test results is what Elizabeth Holmes, founder of the revolutionary blood test company Theranos, thinks will transform medicine and help people find out they are sick sooner in life.

In March 2014, before Brllnt was born, Melanie Charlton, a creative director for a startup, and her brother Jonathan Smalley, then in R&D at Vanderbilt University's School of Medicine, were brainstorming a company in her basement in Annapolis, MarylanIn March 2014, before Brllnt was born, Melanie Charlton, a creative director for a startup, and her brother Jonathan Smalley, then in R&D at Vanderbilt University's School of Medicine, were brainstorming a company in her basement in Annapolis, Marylanin R&D at Vanderbilt University's School of Medicine, were brainstorming a company in her basement in Annapolis, Marylanin her basement in Annapolis, Marylanin Annapolis, Maryland.

According to a report from Goldman Sachs, venture capital in companies pursuing regenerative medicine increased from $ 296 million in 2011 to $ 807 million in 2016, growing about 34 % year over year.

UPDATE: Editas Medicine co-founder Jennifer Doudna left the company in 2014, after just seven months, and has had no additional involvement with the company, according to the company's S - 1 filing.

Brendan Kennedy, the cofounder of Privateer Holdings, which owns various marijuana companies like Marley Natural and Canadian pharmaceutical - grade cannabis producer Tilray, says his companies are expanding abroad while the U.S. Drug Enforcement Agency and the Food and Drug Administration debate whether or not to treat the plant as a medicine or keep it in the same category as heroin.

Recent research published in the Journal of Occupational and Environmental Medicine found the performance of workers with insomnia or sleep problems lags their well - rested colleagues, and that costs companies between $ 2,500 and $ 3,156 annually per sleepy employee.

Some has gone to companies like Twist Bioscience, a San Francisco company developing a proprietary synthetic DNA manufacturing process to aid in diagnostics and the production of personalized medicines and sustainable chemicals.

Matt Wanderer's seven - year - old company, based in Madison, Wisconsin, offers personalized medicines to physicians and patients.

The memory - eating disease, expected to afflict 15 million Americans by 2060 (and tens of millions more around the world as life expectancy increases), has no cure; a new drug for the condition hasn't been approved in well over a decade; initially promising experimental treatments seem to be failing with clockwork regularity; and there's not even a definitive consensus on what, exactly, biopharma companies should focus on while developing Alzheimer's medicines.

You have that coinciding with media stories of companies that have maybe taken advantage of what the U.S. system offers, which is the freedom to price and market your medicines how you want, in a very negative way.

A spokesperson for the drug company told the Financial Times that revenue from increased prices would go to investing in «schemes that ensured more patients could access the medicine.»

• Semma Therapeutics, a Cambridge, Mass. - based biotechnology company focused on the development of novel regenerative medicines, raised $ 114 million in Series B funding.

But the growing number of investors, particularly in Silicon Valley, on the hunt for technologies that do for medicine what apps have done for tech can be a boon for new companies like Theranos whose narratives may be more compelling than their science.

Founded more than two centuries ago by small medicines vendor and namesake Chobei Takeda in Osaka, Japan, the company was that nation's largest pharmaceutical firm by revenue as of 2014.

• ElectroCore, a Basking Ridge, N.J. - based bioelectronic medicine healthcare company, raised more than $ 70 million in Series B funding.

• Outpost Medicine, an Indianapolis and London - based biopharmaceutical company focused on treating urologic and gastrointestinal disorders, raised $ 20 million in funding.

The company's first attempt at publishing research will come in October when Dr. Philip Chenette, a specialist at the Pacific Fertility Center in San Francisco and a medical adviser to Glow, will present at the American Society for Reproductive Medicine's annual conference.

The deal would create a generic medicine powerhouse, giving the combined company critical mass in specialty brands, generics, and over-the-counter and nutritional products.

The study covered 16 companies — nine of which were specific to dermatology while the remaining seven were general medicine websites — totaling in 62 visits.

However, Gliimpse had early investment from Anil Sethi, the company's founder and CEO, who has a long history in medicine while working for Johns Hopkins, among others.

Pfizer (pfe) used to market the medicine under the brand name Epanutin but sold the rights to Flynn, a privately owned British company, in September 2012.

We discovered our lead compounds, cabozantinib and cobimetinib, and advanced them into clinical development before entering into partnerships with leading biopharmaceutical companies in our efforts to bring these medicines to patients globally.

«Her breadth of experience in biomedical research and development can benefit Exelixis greatly as the company recommits its resources to drug discovery and bolstering its pipeline following the successful ongoing commercialization of its lead medicine, CABOMETYX.»

Founded in 1994, Exelixis, Inc. (NASDAQ: EXEL) is a commercially successful, oncology - focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult - to - treat cancers.

When a physician prescribes expensive medications made by a company in which she just happens to own stock, the real risk is not that this won't be the right medicine, but that patients will come to doubt, quite generally, the motives underlying their physicians» decision - making.

Today's deals fall neatly into the pattern of preferred biotech buys in recent years: companies that make medicines for cancer and rare diseases.

They cited the start - up company Zipline, which uses drones to deliver medicines and blood in Rwanda — Quartz called it «Uber for blood» — as the ideal company to invest in.

«There is a revolution taking place in the practice of medicine, particularly cancer therapy, and most of that innovation is taking place in the biotech companies,» said Chris Sassouni, health care specialist and co-portfolio manager of the mid-cap growth investment team at Eagle Asset Management.

• Fortuna Fix, a Canada - based regenerative medicine company, raised $ 25 million in Series B funding.

Innovation comes in many forms, and the company has shown a willingness to apply this same creativity to its drug pricing structure, adhering to the philosophy that medicines should be judged on their worth.

CNBC's Meg Tirrell speaks with Verily Chief Medical Officer Dr. Jessica Mega about the role Alphabet plays in the biotech company and what it could mean for the future of medicine.

Wing is part of X, formerly known as Google X, which is the company's R&D unit working on far - out «moonshot» projects, racing against Amazon and drone makers like DJI to usher in what may one day be a massive new market, delivering everything from food to medicine straight to people's doorsteps.

As the incidents of chronic illness continue to skyrocket, and as the public becomes increasingly frustrated with the limitations of conventional medicine in response, companies across America are taking matters into their own hands.

«The use of the medicines in lethal injections runs counter to the manufacturers» mission to save and enhance patients» lives, and carries with it not only a public - health risk, but also reputational, fiscal and legal risks,» wrote the companies in a friend of the court filing.

In an exclusive interview, Ms. Holmes talks to Medscape Editor - in - Chief Eric J. Topol, MD, about the decade she spent building her company; plans for the present and the future, including a recent deal with Walgreens drugstores; and whether she's on the path to the creative destruction of laboratory medicinIn an exclusive interview, Ms. Holmes talks to Medscape Editor - in - Chief Eric J. Topol, MD, about the decade she spent building her company; plans for the present and the future, including a recent deal with Walgreens drugstores; and whether she's on the path to the creative destruction of laboratory medicinin - Chief Eric J. Topol, MD, about the decade she spent building her company; plans for the present and the future, including a recent deal with Walgreens drugstores; and whether she's on the path to the creative destruction of laboratory medicine.

Medtech giant Becton, Dickinson and Company acquired another US - based medtech company, C.R. Bard, to gain access to Bard's specialized technology in oncology, vascular medicine, urology and sCompany acquired another US - based medtech company, C.R. Bard, to gain access to Bard's specialized technology in oncology, vascular medicine, urology and scompany, C.R. Bard, to gain access to Bard's specialized technology in oncology, vascular medicine, urology and surgery.

It is a fascinating story about a very influential company that has relationships with some of the biggest names in healthcare, including: Oakland, Calif. - based Kaiser Permanente, Cleveland Clinic, Johns Hopkins Medicine in Baltimore, UCLA Health in Los Angeles, Arlington - based Texas Health Resources, Massachusetts General Hospital in Boston, Mount Sinai Health System in New York City and Duke University Health System in Raleigh, N.C.

The California Medical Association, which represents doctors in California, opposes the measure because of that claim, and also because the group said the cancellation of drug purchasing contracts the state already has with pharma companies «would remove many drugs from the Medi - Cal list of pre-approved medicines — creating a new prior authorization hurdle for patients and their physicians.»

Dr. Michael West: The CEO of BioTime, Inc., a leading clinical - stage biotechnology company in the field of regenerative medicine.

In an editorial in The Journal of the American Medical Association, a Stanford School of Medicine professor criticizes the company for operating in «stealth mode for more than a decade» in order to «change the entire health system» without publishing anything in peer - reviewed biomedical journalIn an editorial in The Journal of the American Medical Association, a Stanford School of Medicine professor criticizes the company for operating in «stealth mode for more than a decade» in order to «change the entire health system» without publishing anything in peer - reviewed biomedical journalin The Journal of the American Medical Association, a Stanford School of Medicine professor criticizes the company for operating in «stealth mode for more than a decade» in order to «change the entire health system» without publishing anything in peer - reviewed biomedical journalin «stealth mode for more than a decade» in order to «change the entire health system» without publishing anything in peer - reviewed biomedical journalin order to «change the entire health system» without publishing anything in peer - reviewed biomedical journalin peer - reviewed biomedical journals.

The combined company will benefit from a broader innovative portfolio of leading medicines in key categories and a platform for sustainable growth with diversified payer groups.

The takeover interest in Tesaro underscores the pharmaceutical industry's strong appetite for the acquisition of biotechnology companies with promising medicines under development in lucrative sectors such as cancer treatment.

Just in time for allergy season, allergy medicine company Zyrtec has launched an Alexa skill that shares the daily pollen count for the user's location.

The Health Care sector includes companies engaged in the production and delivery of medicine and health care — related goods and services.

Prior to Norwest Venture Partners, Promod spent 18 years in various operational roles ranging from product development, marketing, Chief Operating Officer and Chief Executive Officer at various public and private companies including Siemens International, Thorn EMI, Emergent Technologies and Dimensional Medicine, Inc..